Attached files

file filename
EX-99.2 - EXHIBIT 99.2 - STAAR SURGICAL COv237857_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - STAAR SURGICAL COv237857_ex99-1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of Earliest Event Reported):
 
October 20, 2011

STAAR Surgical Company
(Exact name of registrant as specified in its charter)
 
Delaware
0-11634
95-3797439
(State or other jurisdiction
(Commission
(I.R.S. Employer
of incorporation)
File Number)
Identification No.)
  
   
1911 Walker Ave, Monrovia, California
 
91016
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code:
 
626-303-7902
 
Not Applicable
Former name or former address, if changed since last report
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 2.02 Results of Operations and Financial Condition.
 
On October 24, 2011 STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended September 30, 2011, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
 
On October 20, 2011 the Company published a press release providing selected preliminary financial results for the quarter ended September 30, 2011, a copy of which is furnished as Exhibit 99.2 to this report and is incorporated herein by this reference.
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
STAAR Surgical Company
 
       
October 25, 2011 
By:
/s/ Barry G. Caldwell  
    Barry G. Caldwell  
    President and Chief Executive Officer  
 
 
Exhibit Index
 
Exhibit No.
Description
99.1 
Press release of the Company dated October 24, 2011.
99.2
Press release of the Company dated October 20, 2011.